Subscribe to Updates
Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.
Author: Daniel snow
Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt shipments of a gene therapy. Source link
Simo will soon be OpenAI’s CEO of Applications. She sees AI as being especially impactful in business and healthcare. Source link
‘The selling agent is long dead’: My $250,000 term life-insurance policy costs $2,000 a month. I’m 80. Is it time to ditch it?
“I took out a $250,000 policy for a 10-year term. At the time, the payments were $200 per month.” Source link
Too many new startup founders think the quickest and most consistent path to continued growth is customer acquisition. Source link
Trump’s budget cuts mean that local governments must work smarter. Source link
Even any good news about the Austin robotaxi rides may not be enough to lift the stock, which has lost about a quarter of its value since a record high in December. Source link
Want to Develop Greater Willpower and Determination? A New Study Shows How to Use the Navy SEAL 40 Percent Rule
Science says staying the course–a key ingredient for success–comes down to personal incentives. Source link
ING says markets are attaching a risk premium to EUR/GBP pair Source link
At the bottom of the president’s foreign policy is a curious void. Source link
Gary Vee’s simple formula for guaranteed financial success is not what you think. Source link